February 11th, 2008- Santa Ana, Ca- Robinson Pharma Inc., (RPI) announced that it has upgraded its soft gel encapsulation capacity with the addition of several new Kamata encapsulators. The Kamata encapsulation machine is recognized as the finest encapsulator available and will improve output by over 200% per production line. Robinson Pharma has commenced a long term project with Kamata to systematically upgrade its production lines to these more efficient and higher output machines.
Robinson Pharma currently operates 22 production lines for soft gel encapsulation and has relied on Korean built Bo-Chang encapsulators. The Bo-Chang machine is a highly reliable and effective encapsulation machine but is limited in production speed. The newer Japanese built Kamata encapsulator is capable of extraordinarily fast and accurate operation. Kamata started building soft gel machines in 1930 and started producing the modern rotary die machine in 1975. The kamata TB-1 machines are distinguished by their ability to effectively handle highly viscous fill materials, a dense die roll design, and simplified operation.
“The new Kamata TB-1 encapsulator, a fully instrumented and automated machine, will improve the consistency and speed of our production giving RPI a distinct advantage over other competitors.” Tuong Nguyen, the president and CEO of Robinson Pharma added “Our ongoing investment in capital improvement will provide for the continued addition of these advanced encapsulation machines and our capacity and speed will continue to improve”.
Robinson Pharma Inc. is a Southern California based, drug licensed and Shuster certified, cGMP compliant full service custom contract manufacturer. RPI features the largest soft gel encapsulation capacity in the US with 22 encapsulation lines producing over 12 billion soft gels per year. Production capabilities include tablet compression, capsule filling, custom imprinting, and a range of packaging options including bottles, blister packaging boxing, and bulk product. Additional services include product development and ingredient sourcing as well as extensive analytical capabilities. Robinson Pharma Inc. provides rapid turnaround on all projects and offers highly competitive pricing. Robinson Pharma Inc. maintains 400,000 square feet of production, operations, and warehousing facilities. For more information please email Sales@RobinsonPharma.com, Phone (714) 241-0235 or visit www.RobinsonPharma.com